ReleaseWire

The Conflict Minerals Rule as defined by Dodd-Frank Section 1502 and the SEC's administration of the Act requires approximately 1,300 US public corporations to conduct a reasonable country of origin inquiry (RCOI) regarding the source of gold, tin, tantalum and tungsten in their products. In today's global economy, this RCOI requirement means that over 20,000 manufacturers who are part of the covered corporations' supply chains must report to their customers their source of conflict minerals. The majority of these 20,000 manufacturers are either private companies or located outside the U.S. Most do not have the resources to adequately satisfy their customers' reporting requirements.

Colitis – Pipeline Review, H1 2015?, provides an overview of the Colitis's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Smoking Cessation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Smoking Cessation and special features on late-stage and discontinued projects.

So what do twelve cities, a tablet and a genius have in common? A tailor-made suit and shirt created affordably, quickly and with such detail the consumer will think they paid thousands. Enter, BookATailor. It's the innovative brainchild of Jacomo Hakim that's taking the bespoke clothing market by storm. Assuring the common consumer that technology's the hero thanks to a Styling Genius armed with a tablet and a measuring tape.

Two innovative CME/CNE programs are now being offered by the Consortium of Multiple Sclerosis Centers (CMSC), the leading educational and professional development organization for MS healthcare professionals. "Diagnosing Multiple Sclerosis" and "Treatment and Management of Multiple Sclerosis" are new virtual simulation programs that are designed to enhance healthcare professionals' treatment of patients with MS through an interactive educational platform.

On Saturday, April 11 2015, Overdrive Productions will host the first annual New York Music Expo. The event will take place at the 70,000 square foot venue of the Resorts World Casino in Queens, New York. The casino will transform into an exhibition hall and will host live performances, informative seminars, and exhibits on new music equipment. Some of the music industries most talented professionals will host interactive workshops.

Report forecast the Cold Chain Logistics market in North America to grow at a CAGR of 14.39 percent over the period 2014-2019.

Report forecast the Global Automotive Safety Systems market to grow at a CAGR of 9.43 percent over the period 2014-2019.

Report forecast the Global Digital Education Publishing market to grow at a CAGR of 15.01 percent over the period 2014-2019.

Strategy Diversification Divested: Productivity measurements, Divestment of non-core assets resulting in healthy Cash position- Will accelerate Next wave of targeted acquisition.

Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets, approaches and biology is discovered. One field which is poised to bring a paradigm change in the way diseases are treated in the next decades is the Stem cell therapy/Regenerative Medicine space. The number of companies and products in the clinic have reached a critical mass warranting a close watch for those interested in keeping pace with the development of new medicines. The Regenerative medicine Universe is large and new companies are being added to it rapidly. As a result we have used some filters to select a few names for a detailed coverage in our Outlook this year.

Domestic sales improved in 2014, recovering from the slump in the 2013 caused by the market's reaction to the new drug pricing policy. In 2015, growth is expected to continue to be healthy, as the momentum continues and improving economic growth allow more spending on healthcare. Sun Pharma acquisition of troubled Ranbaxy helped it to become the leading Indian pharma company in terms of domestic market share. Sun's in-licensing of biologics from Merck also indicates, Indian companies willingness to advance its pipeline towards upper value chain. Though, US market remains the largest market for India generic exports, it is witnessing a slowdown in product approvals and channel consolidation which has impacted overall pricing and margin for the industry. The increase in audits by US FDA staff on the Indian plants of both multinationals and Indian companies have led to an increased number of issuance of warning letters. Indian Pharma companies are trying to diversify into other markets such as Brazil, Mexico, Venezuela and also in some East European markets to lower this growing dependency on the US.

Traditionally Innovation and drug discovery had taken a back seat in the Indian pharma industry with a few blips here and there. However, there have a been a new generation of entrepreneurs who have who ventured into the drug discovery path backed by VC funding and no pharma heritage ! In this Outlook we highlight the names of some select innovation/drug discovery companies who have successfully raised funds to sustain the research, out-licensed some of their assets or are likely to do so in the next 2-3 years thereby rewarding their investors. In this Outlook we have initiated coverage on Connexios, Bugworks, Cellworks, Tergene and hope that soon we will be able to expand the universe further.

All biotech companies - Gilead (GILD), Amgen (AMGN), Biogen Idec (BIIB) and Celgene (CELG), in past year, have given a positive return and hence increased the interest of biotech investors. These companies have been able to select therapy/niche indication where the high treatment cost justifies the need. While large pharma companies are active in M&A deals, the Mature biotech companies are sticking to its core expertise and venturing into unexplored/new therapy; e.g., GILD in anti-cancer and BIIB for hemophilia.

How To Knock A Bravebird From Her Perch (The Morrow Girls Series—Book #1) was published in e-book and paperback formats in January 2014. This riveting novel went on to earn many accolades including a gold medal from the Independent Publisher Book Awards as well as glowing reviews such as…

Report forecast the Combine Harvester market in the US to grow at a CAGR of 3.95 percent and 0.85 percent in terms of value and unit shipments, respectively, during the period 2014-2019.

Report forecast the Dairy Products Transportation market in the APAC region to grow at a CAGR of 8.51 percent over the period 2014-2019.

According to a new market report published by Persistence Market Research "Global Market Study on Sports Equipment: Ball Sports to be the largest segment by 2020", the global Sports Equipment market was valued at USD 66,528.8 million in 2013 and is expected to expand at a CAGR of 3.0% from 2014 to 2020, to reach USD 81,821.0 million by 2020.

According to a new market report published by Persistence Market Research "Global Market Study on Human Insulin: Asia Pacific to Witness fastest Growth by 2020," the global human insulin market was valued at USD 24,332.6 million in 2014 and was expected to grow at a CAGR of 12.4% from 2014 to 2020, to reach an estimated value of USD 49,197.3 million in 2020.

According to a new market report published by Persistence Market Research "Global Market Study on Diagnostic Imaging Devices: Asia-Pacific to Witness Highest Growth by 2020," the global diagnostic imaging devices market was valued at USD 26,477.1 million in 2014 and is expected to grow at a CAGR of 5.2% from 2014 to 2020, to reach an estimated value of USD 35,793.4 million in 2020.

According to a new market report published by Persistence Market Research "Global Market Study on Healthcare Cloud Computing: Hybrid Clouds to Witness Highest Growth by 2020" the global healthcare cloud computing market was valued at USD 4,216.5 million in 2014 and is expected to grow at a CAGR of 20.1% from 2014 to 2020, to reach an estimated value of USD 12,653.4 million in 2020.

According to a new market report published by Persistence Market Research "Global Market Study on Diabetic Nephropathy Market – Asia to Witness Highest Growth by 2020,".The global diabetic nephropathy market was valued at USD 2,262.2 million in 2014 and is expected to grow at a CAGR of 5.6% from 2014 to 2020, to reach an expected value of USD 3,145.9 million in 2020.

According to a new market report published by Persistence Market Research "Global Market Study on HAIs Control Market: Cleaning and Sterilization to Witness Highest Growth by 2020", the global HAIs control market was valued at USD 50,807.0 million in 2014 and is expected to grow at a CAGR of 8.5% from 2014 to 2020, to reach an estimated value of USD 82,889.4 million in 2020.

According to a new market report published by Persistence Market Research "Global Market Study on Sports Supplements: Protein Powder witness highest share in product segment by 2020", the global Sports Supplements market was valued at USD 6,800.8 million in 2013 and is expected to grow at a CAGR of 9.1% from 2014 to 2020, to reach an estimated value of USD 12,449.6 million in 2020.

According to a new market report published by Persistence Market Research "Global Market Study on Beauty Devices: Asia to Witness Highest Growth by 2020," the global beauty devices market was valued at USD 19,389.1 million in 2014 and is expected to grow at a CAGR of 18.7% from 2014 to 2020, to reach an estimated value of USD 54,186.9 million in 2020.